Literature DB >> 21820203

Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment.

Aditya K Gupta1, Chris Drummond-Main, Elizabeth A Cooper, William Brintnell, Bianca Maria Piraccini, Antonella Tosti.   

Abstract

Nondermatophyte mold (NDM) onychomycosis is difficult to diagnose given that NDMs are common contaminants of the nails and of the mycology laboratory. Diagnostic criteria and definition of cure are inconsistent between studies, which may affect the quality of published data. We identified 6 major criteria used in the literature: identification of the NDM in the nail by microscopy (using potassium hydroxide preparation), isolation in culture, repeated isolation in culture, inoculum counting, failure to isolate a dermatophyte in culture, and histology. Most studies used 3 or more of these (range = 1-5). We recommend using at least 3 of the criteria to rule out contamination; these should include potassium hydroxide preparation for direct microscopy and isolation of the organism in culture. We review geographic distribution and clinical presentations associated with different NDMs. The treatment with the greatest quantity of data and highest reported cure rates is terbinafine, for the treatment of Scopulariopsis brevicaulis and Aspergillus species infections. Topicals such as ciclopirox nail lacquer may also be effective (data originating from Scopulariopsis brevicaulis and Acremonium species infections), especially when combined with chemical or surgical avulsion of the nail. We recommend that future studies use (and clearly indicate) at least 3 of the main criteria for diagnosis, and report the clinical type of onychomycosis and the isolated organism. When evaluating different treatments, we suggest that authors clearly define their efficacy outcomes.
Copyright © 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21820203     DOI: 10.1016/j.jaad.2011.02.038

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  39 in total

1.  [Onychocola canadensis Sigler in onychomycosis : A new dermatophyte-like mould in Germany].

Authors:  P Nenoff; B Schorlemmer; S Uhrlaß; A Baunacke; A Baunacke; C Friedrichs; J Iffländer; E Syhre; A Schneider; C Krüger; T Maier
Journal:  Hautarzt       Date:  2016-09       Impact factor: 0.751

Review 2.  Onychomycosis: modern diagnostic and treatment approaches.

Authors:  Georgi Tchernev; Plamen Kolev Penev; Pietro Nenoff; Liliya Georgieva Zisova; José Carlos Cardoso; Teodora Taneva; Gabriele Ginter-Hanselmayer; Julian Ananiev; Maya Gulubova; Reni Hristova; Desislava Nocheva; Claudio Guarneri; G Martino; Nobuo Kanazawa
Journal:  Wien Med Wochenschr       Date:  2012-09-30

3.  Mycoses in northeastern Brazil: epidemiology and prevalence of fungal species in 8 years of retrospective analysis in Alagoas.

Authors:  Fernanda Cristina de Albuquerque Maranhão; Jorge Belém Oliveira-Júnior; Maria Anilda Dos Santos Araújo; Denise Maria Wanderlei Silva
Journal:  Braz J Microbiol       Date:  2019-05-28       Impact factor: 2.476

4.  Onychomycosis due to Neoscytalidium treated with oral terbinafine, ciclopirox nail lacquer and nail abrasion: a pilot study of 25 patients.

Authors:  Ígor B Cursi; Roberta Teixeira Silva; Isabella Brasil Succi; Andréa R Bernardes-Engemann; Rosane Orofino-Costa
Journal:  Mycopathologia       Date:  2012-09-14       Impact factor: 2.574

Review 5.  Onychalgia Causes and Mechanisms: The "GIFTED KID" and the "FOMITE".

Authors:  Athina Fonia; Bertrand Richert
Journal:  Skin Appendage Disord       Date:  2019-12-18

6.  [Infections of finger and toe nails due to fungi and bacteria].

Authors:  P Nenoff; U Paasch; W Handrick
Journal:  Hautarzt       Date:  2014-04       Impact factor: 0.751

7.  [Trichophyton rubrum onychomycosis with secondary Aspergillus versicolor infection in a 12-year-old girl: successful topical therapy with terbinafine-urea ointment].

Authors:  P A Mayser; A Gries; N Hamrouni
Journal:  Hautarzt       Date:  2014-07       Impact factor: 0.751

8.  Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.

Authors:  Chhavi Gupta; Marit Jongman; Shukla Das; K Snehaa; S N Bhattacharya; S Seyedmousavi; Anne D van Diepeningen
Journal:  Mycopathologia       Date:  2016-05-02       Impact factor: 2.574

Review 9.  New Antifungal Agents and New Formulations Against Dermatophytes.

Authors:  Aditya K Gupta; Kelly A Foley; Sarah G Versteeg
Journal:  Mycopathologia       Date:  2016-08-08       Impact factor: 2.574

Review 10.  The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.